Literature DB >> 20582563

The effect of formalin fixation on the levels of brain transition metals in archived samples.

Matthew Schrag1, April Dickson, Arshad Jiffry, David Kirsch, Harry V Vinters, Wolff Kirsch.   

Abstract

Reports that iron, zinc and copper homeostasis are in aberrant homeostasis are common for various neurodegenerative diseases, particularly for Huntington's disease, Parkinson's disease, and Alzheimer's disease. Manipulating the levels of these elements in the brain through the application of chelators has been and continues to be tested therapeutically in clinical trials with mixed results. Much of the data indicating that these metals are abnormally concentrated in Alzheimer's disease and Parkinson's disease brain tissue was generated through the analysis of post-mortem human tissue which was archived in formalin. In this study, we evaluated the effect of formalin fixation of brain on the levels of three important transition metals (iron, copper, and zinc) by atomic absorption spectroscopy. Paired brain specimens were obtained at autopsy for each case; one was conserved by formalin archival (averaging four years), the other was rapidly frozen. Both white and grey matter samples were analyzed and the concentrations of iron and zinc were found to decrease with fixation. Iron was reduced by 40% (P < 0.01), and zinc by 77% (P < 0.0001); copper concentrations increased by 37% (P < 0.05) by the paired T-test. The increase in copper is likely due to contamination from trace copper in the formalin. These results indicate that transition metal data obtained from fixed tissue may be heavily distorted and care should be taken in interpreting this data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20582563      PMCID: PMC3129265          DOI: 10.1007/s10534-010-9359-4

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  19 in total

1.  Serum zinc levels and Alzheimer's disease.

Authors:  L L Rulon; J D Robertson; M A Lovell; M A Deibel; W D Ehmann; W R Markesber
Journal:  Biol Trace Elem Res       Date:  2000       Impact factor: 3.738

2.  Determination of main and trace element contents in human brain by NAA and ICP-AES methods.

Authors:  E Andrási; J Nádasdi; Z Molnar; L Bezur; L Ernyei
Journal:  Biol Trace Elem Res       Date:  1990 Jul-Dec       Impact factor: 3.738

3.  Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.

Authors:  Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Stellan Batsman; David Ames; John Harrison; Colin L Masters; Steve Targum; Ashley I Bush; Ross Murdoch; Janet Wilson; Craig W Ritchie
Journal:  Lancet Neurol       Date:  2008-07-30       Impact factor: 44.182

4.  Elemental imbalances in the olfactory pathway in Alzheimer's disease.

Authors:  D L Samudralwar; C C Diprete; B F Ni; W D Ehmann; W R Markesbery
Journal:  J Neurol Sci       Date:  1995-06       Impact factor: 3.181

5.  Oxidative damage is the earliest event in Alzheimer disease.

Authors:  A Nunomura; G Perry; G Aliev; K Hirai; A Takeda; E K Balraj; P K Jones; H Ghanbari; T Wataya; S Shimohama; S Chiba; C S Atwood; R B Petersen; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

6.  d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.

Authors:  R Squitti; P M Rossini; E Cassetta; F Moffa; P Pasqualetti; M Cortesi; A Colloca; L Rossi; A Finazzi-Agró
Journal:  Eur J Clin Invest       Date:  2002-01       Impact factor: 4.686

7.  Leaching of trace elements from biological tissue by formalin fixation.

Authors:  Kristin Gellein; Trond Peder Flaten; Keith M Erikson; Michael Aschner; Tore Syversen
Journal:  Biol Trace Elem Res       Date:  2007-10-19       Impact factor: 3.738

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Regional brain trace-element studies in Alzheimer's disease.

Authors:  C M Thompson; W R Markesbery; W D Ehmann; Y X Mao; D E Vance
Journal:  Neurotoxicology       Date:  1988       Impact factor: 4.294

10.  Copper, iron and zinc in Alzheimer's disease senile plaques.

Authors:  M A Lovell; J D Robertson; W J Teesdale; J L Campbell; W R Markesbery
Journal:  J Neurol Sci       Date:  1998-06-11       Impact factor: 3.181

View more
  30 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Selective, quantitative measurement of releasable synaptic zinc in human autopsy hippocampal brain tissue from Alzheimer's disease patients.

Authors:  Nicole L Bjorklund; V-M Sadagoparamanujam; Giulio Taglialatela
Journal:  J Neurosci Methods       Date:  2011-09-16       Impact factor: 2.390

3.  Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.

Authors:  Matthew Schrag; Andrew Crofton; Matthew Zabel; Arshad Jiffry; David Kirsch; April Dickson; Xiao Wen Mao; Harry V Vinters; Dylan W Domaille; Christopher J Chang; Wolff Kirsch
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.

Authors:  Matthew Schrag; Claudius Mueller; Udochukwu Oyoyo; Mark A Smith; Wolff M Kirsch
Journal:  Prog Neurobiol       Date:  2011-05-11       Impact factor: 11.685

5.  Preparing adherent cells for X-ray fluorescence imaging by chemical fixation.

Authors:  Lydia A Finney; Qiaoling Jin
Journal:  J Vis Exp       Date:  2015-03-12       Impact factor: 1.355

Review 6.  Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients.

Authors:  Dominic J Hare; Manfred Gerlach; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-09-13       Impact factor: 3.575

7.  Spatial distribution of metals within the liver acinus and their perturbation by PCB126.

Authors:  William D Klaren; David Vine; Stefan Vogt; Larry W Robertson
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-23       Impact factor: 4.223

8.  Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation.

Authors:  Uwe Walter; Marta Skowrońska; Tomasz Litwin; Grażyna Maria Szpak; Katarzyna Jabłonka-Salach; David Skoloudík; Ewa Bulska; Anna Członkowska
Journal:  J Neural Transm (Vienna)       Date:  2014-03-11       Impact factor: 3.575

Review 9.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 10.  Opportunities in multidimensional trace metal imaging: taking copper-associated disease research to the next level.

Authors:  Stefan Vogt; Martina Ralle
Journal:  Anal Bioanal Chem       Date:  2012-10-19       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.